Could a tiny implant shield the rectum from radiation damage?
NCT ID NCT05354427
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at a small implantable spacer placed between the prostate and rectum in men receiving radiation for prostate cancer. The goal was to see if the spacer reduces the radiation dose reaching the rectum, potentially lowering side effects. A total of 175 men who already had the spacer and radiation took part. Researchers measured changes in rectal radiation dose before and after spacer placement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
implantable spacer (a gel-like device placed between the prostate and rectum)
What this could lead to
If effective, this spacer could become a standard tool to reduce rectal side effects from radiation, making treatment safer and more tolerable.
What could go wrong
This is a completed observational study, not a randomized trial, so it cannot prove the spacer works better than no spacer. Individual results may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cuf Porto institution
Porto, Portugal
-
Institute of Maria Skłodowska, Curie (MCMCC)
Warsaw, Poland